ID   OC-3
AC   CVCL_WL09
SY   OC3
DR   Wikidata; Q98128280
RX   CelloPub=CLPUB00500;
RX   PubMed=10390151;
RX   PubMed=11297525;
RX   PubMed=26512696;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7027; Barrett adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
RX   CelloPub=CLPUB00500;
RA   Collins J.K., O'Mahony A., O'Brien F., Corbett A., Morrissey D.,
RA   O'Donoghue M., O'Sullivan G.C.;
RT   "Evaluation of newly established cell lines as models to study
RT   growth, invasion and metastatic spread in oesophageal cancer.";
RL   Fibrinolysis 6 Suppl. 4:83-88(1992).
//
RX   PubMed=10390151; DOI=10.1023/A:1026470417680;
RA   Morrissey D., O'Connell J., Lynch D., O'Sullivan G.C., Shanahan F.,
RA   Collins J.K.;
RT   "Invasion by esophageal cancer cells: functional contribution of the
RT   urokinase plasminogen activation system, and inhibition by antisense
RT   oligonucleotides to urokinase or urokinase receptor.";
RL   Clin. Exp. Metastasis 17:77-85(1999).
//
RX   PubMed=11297525; DOI=10.1074/jbc.M010847200;
RA   Barry O.P., Mullan B., Sheehan D., Kazanietz M.G., Shanahan F.,
RA   Collins J.K., O'Sullivan G.C.;
RT   "Constitutive ERK1/2 activation in esophagogastric rib bone marrow
RT   micrometastatic cells is MEK-independent.";
RL   J. Biol. Chem. 276:15537-15546(2001).
//
RX   PubMed=26512696; DOI=10.3390/cancers7040881; PMCID=PMC4695881;
RA   O'Callaghan C., Fanning L.J., Barry O.P.;
RT   "Hypermethylation of MAPK13 promoter in oesophageal squamous cell
RT   carcinoma is associated with loss of p38delta MAPK expression.";
RL   Cancers (Basel) 7:2124-2133(2015).
//